Pharmaceuticals & Healthcare: Core Views Q110

BMI has introduced greater clarity to its core views for the Pharmaceuticals & Healthcare. Short-term core views concern the period through to the end of the 2011-2013 patent cliff, during which time several blockbuster medicines will lose intellectual property protection. Meanwhile, long-term core views apply to the next decade and beyond.

To read the full article, please choose one of the following options: